Trial NCT05408026

View at ClinicalTrials.gov 
Org. Study IDs: AFT-35

Last trial update was posted on 2023-01-27

MeSH Interventions

Bortezomib Daratumumab Dexamethasone Pomalidomide

MeSH Conditions

Multiple Myeloma Neoplasms, Plasma Cell

Other Conditions

Relapsed or Refractory Multiple Myeloma

Stopping Reasons

Study withdrawn, trial therapy deemed no longer novel and there was a lack of site interest.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID